Happy Anniversary to you my soulmate!” In a private event in Goa, Yash had revealed one of the most interesting things while he was dating Radhika Pandit. While speaking at the event he had revealed ...
Dr. Disrespect defiantly returned to streaming this fall after taking a break in the wake of admitting to inappropriately contacting a minor in a now deleted tweet that he claims was “bait ...
After speaking about how Priyanka Chopra was uncomfortable kissing him onscreen, Annu Kapoor has made another candid statement. This time around, it is about Shah Rukh Khan starrer Chak De India ...
Dr Disrespect says YouTube has postponed his remonetization application, but teased that something “much bigger” could be in the works. In June 2024, former Twitch employees broke their ...
India is based on a famous coach, Negi Saab. But in India, they want to show a Muslim as a good character and make fun of a Pandit (Hindu priest). This is something old, where they use the idea of ...
Witness a much-awaited, turbo charged tabla duet by India’s finest tabla legend with his son Anubrata. Anindo Chatterjee is a phenomenon in the world of Indian classical music. His unique blend of ...
As the morning sun spread on the sprawling housing blocks at Jagti, a Kashmiri pandit colony not very far ... "We are grateful to Dr. Manmohan Singh and former Jammu and Kashmir Governor Jagmohan ...
When it comes to risk capital, Helios Capital's Samir Arora believes that contrary to popular belief, there isn't enough capital to fuel India's growth and foreign capital flows should not be ...
The US manufacturer NorthStar Medical Radioisotopes has unveiled a Contract Development & Manufacturing (CDMO) facility dedicated to the production and development of medical radioisotopes.
The deal was announced Thursday morning, confirming an earlier report from The Wall Street Journal.
Rentschler Biopharma plans to expand and upgrade the manufacturing site at the family-owned CDMO’s headquarters in Laupheim, Germany, with the addition of a buffer media station. Although ...